Clinical Trials Directory

Trials / Unknown

UnknownNCT06113276

Quantitative Computed Tomography for Mortality Risk Stratification in ARDS

Status
Unknown
Phase
Study type
Observational
Enrollment
210 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Acute respiratory distress syndrome remains a deadly disease with hospital mortality remaining between 40 to 50%. ARDS mortality risk factors have been identified from patient history, common clinical and biological variables in the lung SAFE study. Part of ARDS mortality is attributable to ventilator-induced lung injury (VILI), in relation with inappropriate settings on the ventilator. Tidal hyperinflation and recruitment/derecruitment during lung inflation are 2 identified mechanisms leading to VILI, that may be identified on computed tomography while poorly identified with variables collected at the bedside. The aim of this study is to identify whether tidal hyperinflation identified on computed tomography is a risk factor for ARDS mortality, independently from know bio-clinical risk factors.

Conditions

Interventions

TypeNameDescription
RADIATIONLow dose computed tomography to evaluate biomechanical parameters in the lungIn the participating to the study, response to PEEP increase and tidal inflation are evaluated with a software computing biomechanical parameters (tidal hyperinflation and lung recruitability). Tidal hyperinflation and recruitment are computed on CT images acquired within 72 hours after ARDS onset or with 72h after ECMO onset.

Timeline

Start date
2020-11-06
Primary completion
2024-11-01
Completion
2025-05-01
First posted
2023-11-02
Last updated
2024-01-31

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06113276. Inclusion in this directory is not an endorsement.